Location: 7 Days Live Virtual Class Room
Dates: November 18-26, 2024
Live Course Fee: $1,495.00
Add To CartNovember 18 - 24, 2024 Live course dates & hours (PST):
November 18 - Monday 8 AM - 5 PM Pacific Standard Time
November 19 - Tuesday 8 AM - 5 PM Pacific Standard Time
November 20 - Wednesday 8 AM - 5 PM Pacific Standard Time
November 21 - Thursday 8 AM - 5 PM Pacific Standard Time
November 22 - Friday 8 AM - 5 PM Pacific Standard Time
November 23 - Saturday (OFF) NO CLASS
November 24 - Sunday (OFF) NO CLASS
November 25 - Monday 8 AM - 5 PM Pacific Standard Time
November 26 - Tuesday 8 AM - 5 PM Pacific Standard Time
Note: 8 AM - 5 PM Pacific time = 11 AM - 8 PM Eastern Standard Time
Notes:
1. After registration, if you need to postpone your live class attendance to a future date, you can do so by emailing us. The next Live class will be in November with dates to be determined. Note: Board review classes are non-refundable.
2. The registration deadline to receive coursebooks in time is November 8th.
3. NO LAW lectures: The 7-day Live board review is solely CLINICAL pharmacy lectures for NAPLEX and the Clinical portion of CPJE. The Law portion of CPJE is covered by CA Law Online Course.
6-month access to Online Question Bank is included with the Live course: 2500 Board-type questions with answers, detailed explanations & patient profile cases to solidify your understanding of the material.
The questions are formatted to include patient profiles, fill-in-the-blank calculations, and standard multiple-choice questions.
Progress Tracking allows you to follow and manage your question bank results, and evaluate your progress on your user dashboard. At the end of your study, we have two comprehensive practice tests to conclude the material that has been covered.
RN, a 56-year-old male patient, presents to the ER with progressively worsening shortness of breath when walking more than 20 feet, fatigue, and bilateral pitting edema of his legs for the last few months.
Past Medical History:
DM type 2
Long-standing hypertension
Current Medications:
Metformin 1000 mg PO BID
Pioglitazone 30 mg PO once daily
Hydrochlorothiazide 25 mg PO once daily
Lisinopril 40 mg PO once daily
Amlodipine 10 mg PO once daily
Vitals: BP: 110/63 mmHg P: 110, Resp Rate: 22 Temp: 97.8
Labs:
BUN ................................ 19 mg/dL (6-20)
Serum Creatinine ............. 1.1 mg/dL (0.6-1.2)
Potassium ....................... 3.1 mEq/L (3.5-5.2)
BNP ................................ 960 (10-300)
Troponins ....................... Negative
Imaging Studies:
Chest x-ray: Enlarged cardiac silhouette, mild pulmonary edema
Echocardiogram: Ejection Fraction: 30%
Which of his medications may be worsening his pulmonary edema and leg edema symptoms? Select ALL that apply.
MK is a 49-year-old male with history of liver cirrhosis. He is brought to ER by family members with a chief complaint of confusion and altered mental status for the last 24 hours.
On exam, MK is difficult to arouse; he is not oriented to time, person or place.
Vitals: BP: 110/67 mmHg P: 80 RR: 14 Temp 98.6
Labs:
Comprehensive Metabolic Panel:
INR …………………. 2.1
Urine analysis & Lumbar puncture results are normal.
Which of the following treatment measures do you recommend? Select ALL that apply.
Which of the following medications are used to treat hyperphosphotemia of ESRD? Select ALL that apply.
DB is a 67-year-old male with ESRD on dialysis who has been on Epogen 3000 units SC three times a week for anemia of chronic renal failure. His recent labs are as follows:
Hgb …………………. 12.6 g/dL (13.5 – 16.5 g/dL for males)
Hct …………………… 38.6 % (40% – 52%)
MCV …………………. 86 fL
WBC ………………… 4.0 thous/microL
Platelets …………….. 185 thous/microL
With regards to his Epogen dosing, what would be the most appropriate course of action?
Which of the following is NOT a suspending agent?
This is a list of ALL the topics covered in the coursebook and the Online video lectures.
Please note due to time constraints, some of the topics below (covered in the coursebook and online course) will NOT be lectured on during the Live Review.
Hypertension Hypertensive emergency Congestive Heart Failure Atrial Fibrillation Anti-Arrhythmics Anti-Coagulants Anti-platelets Thrombolytics Stroke Angina Acute Coronary Syndrome Myocardial Infarction Autonomic Nervous System Dyslipidemia Interpreting LABS Electrolytes Metabolic panels Renal and Hepatic dysfunction CBC and Anemias Asthma & COPD Nebulizers and MDIs Diabetes Mellitus Chemotherapy Osteoporosis Contraceptives Womens' health Rheumatoid Arthritis GERD / PUD Pregnancy Smoking Cessation Pain Management Muscle Relaxants Insomnia Medication Safety |
Patient Profiles / Inpatient cases Calculations Statistics Compounding IV Incompatibilities TPN Ulcerative Colitis Crohn's disease Irritable Bowel Syndrome Multiple Sclerosis Transplant Drugs Antibiotics Antivirals Antifungals Tuberculosis HIV / AIDS Immunizations Anxiety and related disorders Depression Bipolar disorder Schizophrenia Parkinson's CNS Stimulants Weight loss Alzheimer's Migraine Seizure Gout Herbals OTC Thyroid Meds Ophthalmic Meds Cystic Fibrosis Sickle Cell Disease Erectile Dysfunction
|